A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HMSN / hollow mesoporous silica nanoparticles

[Related PubMed/MEDLINE]
Total Number of Papers: 21
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HMSN  (>> Co-occurring Abbreviation)
Long Form:   hollow mesoporous silica nanoparticles
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Dendritic Mesoporous Silica Hollow Spheres for Nano-Bioreactor Application. ---
2022 Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and Their Sustained-Release Properties. DMSN, MSN, PUE
2022 Space-confined growth of nanoscale metal-organic frameworks/Pd in hollow mesoporous silica for highly efficient catalytic reduction of 4-nitrophenol. MOFs
2022 Wound microenvironment-responsive glucose consumption and hydrogen peroxide generation synergistic with azithromycin for diabetic wounds healing. AZM, GOx
2021 pH/GSH-Dual-Sensitive Hollow Mesoporous Silica Nanoparticle-Based Drug Delivery System for Targeted Cancer Therapy. beta-CD, cit, DDSs
2020 Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721. NIR, PTT
2020 Wound therapy via a photo-responsively antibacterial nano-graphene quantum dots conjugate. E. coli, EM, EM, GQDs, LED, PDT, S. aureus
2019 Biodegradable hybrid mesoporous silica nanoparticles for gene/chemo-synergetic therapy of breast cancer. HA, HAase, PEI
2018 Design and Investigation of Core/Shell GQDs/hMSN Nanoparticles as an Enhanced Drug Delivery Platform in Triple-Negative Breast Cancer. DOX, GQDs, NIR, NPs
10  2018 Preparation of core/shell CdTe@hMSN for enhanced tumor vasculature-specific drug delivery. DOX, QDs, VEGF
11  2018 Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications. IND, PET, SiNPs
12  2018 Synthesis and Characterization of Hollow Mesoporous Silica Nanoparticles for Smart Corrosion Protection. BET, MSN, PDDA
13  2017 Active targeting co-delivery system based on hollow mesoporous silica nanoparticles for antitumor therapy in ovarian cancer stem-like cells. DOX
14  2017 Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma. AEG-1, DOX, HCC, LH, MDR, P-gp
15  2017 Hyaluronic acid and carbon dots-gated hollow mesoporous silica for redox and enzyme-triggered targeted drug delivery and bioimaging. CLSM, DDS, DOX, FCM, HA, PEI
16  2016 Lipid-coated hollow mesoporous silica nanospheres for co-delivery of doxorubicin and paclitaxel: Preparation, sustained release, cellular uptake and pharmacokinetics. L-HMSN, PBS
17  2016 Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release. CS
18  2016 Template-Free Synthesis of Hollow/Porous Organosilica-Fe3O4 Hybrid Nanocapsules toward Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound Therapy. HIFU, MRI, NP, OSNC
19  2015 A soft-hard template approach towards hollow mesoporous silica nanoparticles with rough surfaces for controlled drug delivery and protein adsorption. APTES, CTAB, cyt c, DOX
20  2015 Single peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cells. HUVECs
21  2014 Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy. NIRF, PET